On Friday, Arrowhead Pharmaceuticals Inc (ARWR) stock saw a decline, ending the day at $26.03 which represents a decrease of $-0.12 or -0.46% from the prior close of $26.15. The stock opened at $26.15 ...

Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Sell rating on Sarepta Therapeutics (SRPT – Research Report) and decreased the price ...

Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kostas ...

Alight, Inc. , a leading cloud-based human capital and technology-enabled services provider, today announced that its Chief Financial Officer, Jeremy Heaton, will present at the UBS Global Technology ...

Tune in for a fireside chat with John Stankey at the UBS Global Media & Communications Conference, scheduled to begin at 8:15 a.m. ET. Webcast available live and for replay. Key Takeaways: AT&T to ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) had its target price trimmed by Sanford C. Bernstein from $27.00 to $24 ...